Skip to main content
. 2022 Sep 16;14(18):4498. doi: 10.3390/cancers14184498

Figure 4.

Figure 4

(A) MA plots indicating the results of supervised investigation by differential expression analyses in 65 patients treated with nCT/nCRT from the AUMC discovery cohort. Differentially expressed genes in red between patients with Mandard 1 versus higher Mandard scores (left upper plot) and pTx versus higher pT stadia (left lower plot). (B) Heatmap indicating GSEA results for patients treated with nCT/nCRT from the AUMC cohort. In red, enriched KEGG pathways in patients with Mandard 1, and in blue, enriched KEGG pathways in patients with higher Mandard scores.